These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 28277136)

  • 21. Phoenixin-14 concentrations are increased in association with luteinizing hormone and nesfatin-1 concentrations in women with polycystic ovary syndrome.
    Ullah K; Ur Rahman T; Wu DD; Lin XH; Liu Y; Guo XY; Leung PCK; Zhang RJ; Huang HF; Sheng JZ
    Clin Chim Acta; 2017 Aug; 471():243-247. PubMed ID: 28624500
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Beneficial phytoestrogenic effects of resveratrol on polycystic ovary syndromein rat model.
    Zhang N; Zhuang L; Gai S; Shan Y; Wang S; Li F; Chen L; Zhao D; Liu X
    Gynecol Endocrinol; 2021 Apr; 37(4):337-341. PubMed ID: 32851887
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Blood nesfatin-1 levels in patients with polycystic ovary syndrome: a systematic review and meta-analysis.
    Wang M; Tong J; Zhu Q; Tang H; Tang L
    Front Endocrinol (Lausanne); 2023; 14():1275753. PubMed ID: 38327900
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Circulating nesfatin-1 levels in women with polycystic ovary syndrome: A systematic review and meta-analysis.
    Sobhan Bahreiny S; Ahangarpour A; Asghar Hemmati A; Kazemzadeh R; Bastani MN; Reza Dabbagh M; Aghaei M
    Int J Reprod Biomed; 2023 Oct; 21(10):777-788. PubMed ID: 38077942
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased Serum Levels of Phoenixin-14, Nesfatin-1 and Dopamine Are Associated with Positive Pregnancy Rate after Ovarian Stimulation.
    Piróg M; Jach R; Ząbczyk M; Natorska J
    J Clin Med; 2023 Nov; 12(22):. PubMed ID: 38002606
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regulation and physiological functions of phoenixin.
    Liang H; Zhao Q; Lv S; Ji X
    Front Mol Biosci; 2022; 9():956500. PubMed ID: 36090042
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Review of Novel Potential Insulin Resistance Biomarkers in PCOS Patients-The Debate Is Still Open.
    Kruszewska J; Laudy-Wiaderny H; Kunicki M
    Int J Environ Res Public Health; 2022 Feb; 19(4):. PubMed ID: 35206286
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Role of the Gastric Hormones Ghrelin and Nesfatin-1 in Reproduction.
    Schalla MA; Stengel A
    Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681721
    [TBL] [Abstract][Full Text] [Related]  

  • 29. DLK1 and Nesfatin-1 levels and the relationship with metabolic parameters in polycystic ovary syndrome: Prospective, controlled study.
    Demir Çaltekin M; Caniklioğlu A; Eris Yalçın S; Aydoğan Kırmızı D; Baser E; Yalvaç ES
    Turk J Obstet Gynecol; 2021 Jun; 18(2):124-130. PubMed ID: 34083652
    [TBL] [Abstract][Full Text] [Related]  

  • 30. NUCB2/Nesfatin-1 in the Blood and Follicular Fluid in Patients with Polycystic Ovary Syndrome and Poor Ovarian Response.
    Catak Z; Yavuzkir S; Kocdemir E; Ugur K; Yardim M; Sahin İ; Agirbas EP; Aydin S
    J Reprod Infertil; 2019; 20(4):225-230. PubMed ID: 31897389
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A new rat model exhibiting both ovarian and metabolic characteristics of polycystic ovary syndrome.
    Mannerås L; Cajander S; Holmäng A; Seleskovic Z; Lystig T; Lönn M; Stener-Victorin E
    Endocrinology; 2007 Aug; 148(8):3781-91. PubMed ID: 17495003
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Emerging roles of NUCB2/nesfatin-1 in the metabolic control of reproduction.
    García-Galiano D; Tena-Sempere M
    Curr Pharm Des; 2013; 19(39):6966-72. PubMed ID: 23537080
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Basic research in PCOS: are we reaching new frontiers?
    Ben-Shlomo I; Younis JS
    Reprod Biomed Online; 2014 Jun; 28(6):669-83. PubMed ID: 24768413
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of nesfatin-1 expression in letrozole-induced polycystic ovaries in the rat.
    Xu Y; Zhang H; Li Q; Lao K; Wang Y
    Gynecol Endocrinol; 2017 Jun; 33(6):438-441. PubMed ID: 28277136
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nesfatin-1 and other hormone alterations in polycystic ovary syndrome.
    Deniz R; Gurates B; Aydin S; Celik H; Sahin I; Baykus Y; Catak Z; Aksoy A; Citil C; Gungor S
    Endocrine; 2012 Dec; 42(3):694-9. PubMed ID: 22367584
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of anti-Müllerian hormone in letrozole rat model of polycystic ovary syndrome.
    Du DF; Li XL; Fang F; Du MR
    Gynecol Endocrinol; 2014; 30(12):885-9. PubMed ID: 25170777
    [TBL] [Abstract][Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.